Explore how Abbott is transforming cardiovascular care through AI, minimally invasive devices, and digital health technologies, enhancing patient outcomes and accessibility in healthcare.

Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery ...

Abbott said Tuesday it received Food and Drug Administration approval for the Tendyne transcatheter mitral valve replacement system to treat calcium buildup in the ring that supports the heart ...

Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery PR Newswire Tue, May 27, 2025, 9:00 AM 3 min read ...

Abbott’s MitraClip implant just got a new sibling. The FDA has approved the company’s Tendyne system, as a minimally invasive heart replacement for patients with mitral valve disease that ...

And if we get a big upside surprise from Libre or a new device (or if sector sentiment turns risk-on), I could see Abbott ripping to $160 without breaking a sweat. Where I'd Buy So here's how I'd ...

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC)Tendyne offers ...

Abbott Park, Illinois Thursday, May 29, 2025, 16:00 Hrs [IST] Abbott announced the US Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement (TMVR ...